Viewpoints

Oct 19, 2017
By Pharmaceutical Technology Editors
How soon could the pharmaceutical industry see a widespread adoption of emerging technologies that are poised to shape its future?
Oct 02, 2017
Pharmaceutical Technology
Focusing on whether the product meets its defined quality attributes should help one make reasonable, documentable, and defendable risk-based decisions, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
Oct 02, 2017
Pharmaceutical Technology
Reeling from financial and tropical storms, Puerto Rico needs stable industry for recovery.
Sep 08, 2017
Six years after the guidance, it’s time to change our quality assurance vocabulary.
Sep 02, 2017
Pharmaceutical Technology
The differences between the quality control and quality assurance units can be found in their names, according to Siegfried Schmitt, principal consultant at PAREXEL.
Aug 02, 2017
Pharmaceutical Technology
Amid contentious debate about “fake news,” peer-review papers offer vital, objective insight.
Aug 02, 2017
Pharmaceutical Technology
The review of batch records creates a story of the materials, manufacturing, and packaging involved in the production of bio/pharmaceuticals, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
Jun 05, 2017
The author shares his opinion on the challenges presented by the Internet of Things and what companies need to consider when choosing suitable architectures to manage serialization data.
Jun 02, 2017
Pharmaceutical Technology
New reports indicate that drug prices are slowing compared to other healthcare costs.
Jun 02, 2017
Pharmaceutical Technology
Informing your clients of possible changes in equipment is imperative when upgrading a laboratory, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
native1_300x100
lorem ipsum